TL;DR: The Centers for Medicare & Medicaid Services modified NCD 173 governing the Vabra Aspirator, effective March 7, 2026. Here's what changes for billing teams.
CMS Vabra Aspirator coverage policy under NCD 173 Medicare has one hard rule that determines reimbursement or denial: the patient must be symptomatic. This NCD 173 Medicare update clarifies coverage for the Vabra Aspirator — a sterile, disposable vacuum device used to collect uterine tissue for endometrial carcinoma detection. The policy does not list specific CPT or HCPCS codes, which creates documentation risk your billing team needs to address now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Vabra Aspirator — NCD 173 |
| Policy Code | NCD 173 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Gynecology, Obstetrics & Gynecology, Outpatient Hospital Diagnostic Services |
| Key Action | Confirm active symptom documentation in the medical record before billing for any Vabra Aspirator procedure or related diagnostic service |
CMS Vabra Aspirator Coverage Criteria and Medical Necessity Requirements 2026
The core medical necessity rule here is straightforward. Medicare covers the Vabra Aspirator and related diagnostic services only when the patient shows clinical symptoms or signs of endometrial disease. The policy specifically names irregular or heavy vaginal bleeding as qualifying indicators.
That's the complete medical necessity threshold. The patient must be symptomatic. No symptoms, no coverage — full stop.
This matters because the Vabra Aspirator sits in a category where the line between diagnostic and routine screening can blur in documentation. Gynecology billing teams sometimes see these procedures documented as part of a broader workup without a clearly stated presenting complaint. That gap will trigger a claim denial under this policy.
The benefit category is Diagnostic Services in Outpatient Hospital and Diagnostic Tests (other). Whether Medicare considers the Vabra Aspirator covered under Medicare as a diagnostic tool depends entirely on what's in the patient's chart before the procedure. "Uterine tissue collection" without a documented symptom driving the clinical decision is not enough.
Prior authorization is not explicitly required under NCD 173 as written. But the absence of a prior auth requirement doesn't reduce your documentation burden — it shifts it entirely to the claim and medical record. Your MAC will look for the symptom-to-procedure link at audit.
The coverage policy also cross-references NCD 230.5, which governs the Gravlee Jet Washer — a related endometrial sampling device. If your practice bills for both devices, apply the same symptomatic patient standard to both. The Medicare Benefit Policy Manual, Chapter 16, §90 provides additional guidance and is worth pulling if you're building internal billing guidelines for these procedures.
CMS Vabra Aspirator Exclusions and Non-Covered Indications
The policy is explicit about what's not covered. CMS will not pay for the Vabra Aspirator or any related diagnostic services when used on an asymptomatic patient.
This exclusion flows directly from §1862(a)(7) of the Social Security Act, which prohibits Medicare payment for routine physical checkups. The policy uses that statutory prohibition to draw a hard line: if the procedure happens during a routine exam — without a documented presenting symptom — Medicare won't pay. Not for the device. Not for the related diagnostic services. Nothing.
This is the real exposure point for Ob-Gyn billing teams. Endometrial sampling done "while the patient is here anyway" during a wellness visit is not covered. The procedure must be driven by a documented clinical finding or complaint.
The term "asymptomatic" in this context means the patient had no presenting symptoms of endometrial disease at the time of the encounter. If you're billing for a procedure done during a preventive visit and the documentation doesn't clearly separate the diagnostic service from the routine exam, expect a denial.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Patient with clinical symptoms of endometrial disease (e.g., irregular or heavy vaginal bleeding) | Covered | Not specified in policy | Symptom must be documented in the medical record; covers device and related diagnostic services |
| Asymptomatic patient — routine screening or checkup | Not Covered | Not specified in policy | Excluded under §1862(a)(7) of the Social Security Act; no reimbursement for device or related services |
| Endometrial tissue collection during routine physical exam | Not Covered | Not specified in policy | Prohibited regardless of other findings; documentation must clearly separate from preventive services |
CMS Vabra Aspirator Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 means this modified policy is already governing claims. If your team hasn't reviewed workflows against this standard, do it now.
| # | Action Item |
|---|---|
| 1 | Audit your documentation requirements before billing. Every Vabra Aspirator claim needs a documented presenting symptom — specifically clinical signs of endometrial disease — in the chart. Irregular or heavy vaginal bleeding is the clearest qualifying indicator named in the policy. Make sure your providers are capturing this before the procedure, not as an afterthought. |
| 2 | Flag any encounters where the procedure happened during a routine or wellness visit. These are your highest-risk claims. If the documentation doesn't explicitly separate the diagnostic service from the routine exam, pull the claim and review it before submission. A claim that links Vabra Aspirator use to a preventive visit will not survive an audit. |
| 3 | Check your charge capture workflow for symptom verification. Build a hard stop or checklist item that confirms a qualifying symptom is documented before the Vabra Aspirator code goes on the claim. This isn't optional documentation hygiene — it's the medical necessity gate the policy requires. |
| 4 | Review the Gravlee Jet Washer billing guidelines under NCD 230.5. Both devices are used for endometrial sampling. Both are governed by the same symptomatic patient standard. If your practice uses either device, apply consistent documentation requirements across both. A denial pattern on one is a warning sign for the other. |
| 5 | Pull the Medicare Benefit Policy Manual, Chapter 16, §90. CMS cross-references this section in NCD 173. It provides supplementary guidance on how Medicare interprets coverage for these procedures. Your compliance officer should review it alongside this NCD to catch any nuance that affects your patient population or billing mix. |
| 6 | Note that NCD 173 does not list specific CPT or HCPCS codes. This is unusual and creates ambiguity. Your billing team needs to confirm which procedure codes your MAC recognizes for Vabra Aspirator services. Contact your Medicare Administrative Contractor directly if you're not certain which codes to use — because submitting under the wrong code is a denial waiting to happen, regardless of documentation quality. |
| 7 | If your billing mix includes a high volume of Ob-Gyn diagnostic procedures, loop in your compliance officer. The asymptomatic exclusion and the routine exam prohibition create two separate denial pathways. Understanding how your specific documentation practices interact with both requires more than a policy read — it requires a review of actual claim patterns. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vabra Aspirator Under NCD 173
Covered Codes (When Medical Necessity Criteria Are Met)
The policy does not list specific CPT or HCPCS codes for Vabra Aspirator billing. This is a known gap in NCD 173 as written.
To bill correctly under this policy, contact your Medicare Administrative Contractor to confirm which procedure codes they accept for Vabra Aspirator services and related diagnostic procedures. Local coverage determinations from your MAC may provide additional code-level guidance where the NCD is silent.
| Code | Type | Description |
|---|---|---|
| Not specified in NCD 173 | — | Contact your MAC for applicable procedure codes |
Not Covered Codes
The policy excludes Vabra Aspirator services and related diagnostic codes when billed in connection with an asymptomatic patient or routine physical examination. The exclusion applies regardless of which procedure code is used — coverage status is determined by patient symptoms at the time of service, not by the code itself.
Key ICD-10-CM Diagnosis Codes
NCD 173 does not specify ICD-10-CM codes. However, based on the clinical indications named in the policy, the diagnosis on the claim should reflect documented endometrial disease symptoms. Work with your coding team to identify the appropriate ICD-10-CM codes for irregular uterine bleeding, heavy menstrual bleeding, or other endometrial disease indicators that match the documented clinical findings.
Do not attach a screening or preventive diagnosis code to a Vabra Aspirator claim. That combination — a preventive diagnosis with a diagnostic procedure — is exactly the pattern the §1862(a)(7) exclusion targets.
The Real Issue With NCD 173
The absence of specified codes in this policy is a practical problem, not a minor oversight. Most billing teams expect a National Coverage Determination to give them either a covered code list or an explicit not-covered designation. NCD 173 does neither.
What you get instead is a coverage rule built entirely on clinical context: symptomatic versus asymptomatic. That means your denial risk lives entirely in documentation and code selection at the local level — not in the NCD itself.
This is similar to older NCDs where CMS set the coverage principle and left the procedural coding to local contractors. It was common before the ICD-10 and CPT era matured. But it creates a real gap for billing teams today, because "call your MAC" is not a scalable workflow when you're processing claims at volume.
If you're billing Vabra Aspirator services with any regularity, build a payer-specific billing guideline document that captures what your MAC has told you about acceptable codes. Keep it updated. The NCD won't do that work for you.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.